Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A new canine version of Prozac will soon be available. It is just the latest in pet-specific drugs, as pharmaceutical companies increasingly chase this lucrative market.
The FDA is poised to decide whether biotech animals should be sold as food.
Studying the club drug could bring about faster-acting and more-effective treatments.
A federal investigation finds conflicting test results and false marketing claims.
A plastic from recombinant E. coli gets FDA approval for use in safer, ultrastrong sutures.
The FDA plans to overhaul its regulation of the increasingly common diagnostic tests.
A new kind of tattoo ink could make removal a lot easier.
A startup called Genome Liberty is developing a consumer genetics test to gauge an individual’s ability to metabolize prescription drugs.
Researchers are developing quick-brew vaccines and ones that catch multiple strains of flu.